Adam Aulbach, DVM, DACVP

Adam Aulbach, DVM, DACVP, has served as Inotiv’s vice president of pathology since 2021. In this role he works to ensure that our clients receive high-quality integrated pathology and clinical pathology services on time. Adam serves as the primary liaison for external clients and internal laboratory functions within our pathology, clinical pathology, biomarker, and special assays groups. More specifically he coordinates and monitors study-specific activities that require subject matter expertise in clinical pathology, advanced biomarkers, and immunotoxicology. With almost two decades of professional pathology experience, he provides Inotiv with an in-depth understanding of clinical pathology that guarantees our team will deliver.

Before joining Inotiv’s team, Aulbach earned his DVM from the University of Missouri-Columbia in 2002 and completed a residency in toxicologic clinical pathology at Michigan State University and MPI research in 2007. He served as a principal clinical pathologist at MPI Research, where in 2011 he advanced to the position of a scientific director in clinical pathology, biomarkers, and immunotoxicology. He became an adjunct assistant professor in 2012 at Michigan State University and was selected as the Head of Biomarker Center of Excellence at Charles River Laboratories. Since joining Inotiv in 2021 he has provided exceptional leadership guidance garnered from his many years of experience working the pharmaceutical and biologics development space.

Back to Team